Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

IRON

Disc Medicine Inc

Jul 26 • 04:00PM ET

45.67

Dollar change +1.75
Percentage change 3.98	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI IWM VXF XBI IWN IBB SCHA VTWO VHT IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.38	Insider Own	45.36%	Shs Outstand	24.36M	Perf Week	0.59%
Market Cap	1.36B	Forward P/E	-	EPS next Y	-5.09	Insider Trans	2.73%	Shs Float	16.21M	Perf Month	5.21%
Income	-80.60M	PEG	-	EPS next Q	-1.10	Inst Own	51.08%	Short Float	10.11%	Perf Quarter	72.21%
Sales	0.00M	P/S	-	EPS this Y	-38.99%	Inst Trans	3.39%	Short Ratio	4.26	Perf Half Y	-27.85%
Book/sh	13.69	P/B	3.34	EPS next Y	-7.06%	ROA	-26.96%	Short Interest	1.64M	Perf Year	-0.91%
Cash/sh	11.55	P/C	3.95	EPS next 5Y	-	ROE	-28.23%	52W Range	25.60 - 77.60	Perf YTD	-20.93%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-23.75%	52W High	-41.15%	Beta	0.57
Dividend TTM	-	Quick Ratio	23.70	Sales past 5Y	0.00%	Gross Margin	-	52W Low	78.40%	ATR (14)	2.52
Dividend Ex-Date	-	Current Ratio	23.70	EPS Y/Y TTM	29.92%	Oper. Margin	0.00%	RSI (14)	53.39	Volatility	4.73% 5.71%
Employees	74	Debt/Eq	0.01	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.33	Target Price	64.33
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	9.62%	Payout	-	Rel Volume	0.57	Prev Close	43.92
Sales Surprise	-	EPS Surprise	-8.11%	Sales Q/Q	-	Earnings	May 09 BMO	Avg Volume	384.68K	Price	45.67
SMA20	-0.70%	SMA50	11.63%	SMA200	-7.98%	Trades		Volume	217,371	Change	3.98%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-01-24	Downgrade	Raymond James	Strong Buy → Outperform	$40
Dec-19-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$56 → $65
Jun-09-23	Upgrade	Raymond James	Outperform → Strong Buy	$50 → $75
Jun-07-23	Initiated	H.C. Wainwright	Buy	$55
May-17-23	Initiated	Raymond James	Outperform	$50
Apr-28-23	Initiated	Cantor Fitzgerald	Overweight	$45
Apr-21-23	Initiated	Stifel	Buy	$37
Apr-20-23	Initiated	Morgan Stanley	Overweight	$37
Mar-23-23	Initiated	BMO Capital Markets	Outperform	$40
Feb-28-23	Initiated	SVB Securities	Outperform	$36

Jun-28-24 08:11PM	Bitfarms Technologies, Vestis, and More Stocks See Action From Activist Investors (Barrons.com)
Jun-14-24 08:03AM	Disc Medicine Announces Underwritten Offering of Common Stock (GlobeNewswire) +18.16%
07:30AM	Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 Congress (GlobeNewswire)
May-30-24 09:00AM	Disc Medicine to Participate in the Jefferies Global Healthcare Conference (GlobeNewswire)
May-14-24 10:30AM	Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress (GlobeNewswire)
08:00AM	Loading…
May-13-24 08:00AM	Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference (GlobeNewswire)
May-11-24 05:31AM	Disc Medicine Inc (IRON) Reports Q1 2024 Earnings: A Detailed Financial Overview (GuruFocus.com)
May-09-24 01:54PM	IRON Stock Earnings: Disc Medicine Misses EPS for Q1 2024 (InvestorPlace)
08:00AM	Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Apr-02-24 02:24PM	Disc Medicine (IRON) Down on Mixed Results From AURORA Study (Zacks) -6.36%
Apr-01-24 04:19PM	Disc Medicine Plummets After Placebo Effect Confounds Sunlight Sensitivity Study (Investor's Business Daily) -45.05%
08:00AM	Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) (GlobeNewswire)
Mar-23-24 05:31AM	Disc Medicine Inc (IRON) Reports Earnings: A Detailed Look at Fiscal Performance (GuruFocus.com)
Mar-21-24 08:00AM	Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire) -7.52%
Mar-06-24 04:30PM	Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024 (GlobeNewswire) -5.18%
08:30AM	Loading…
Feb-26-24 08:30AM	Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer (GlobeNewswire)
Feb-20-24 08:30AM	Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease (GlobeNewswire)
Feb-09-24 09:00AM	Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia Vera (GlobeNewswire)
Feb-07-24 08:00AM	Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating Officer (GlobeNewswire)
Jan-03-24 05:00PM	Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-22-23 06:35PM	Peabody Energy, Janus International, and More Stocks See Action From Activist Investors (Barrons.com)
Dec-20-23 04:30PM	Disc Medicine Announces Retirement of Brian MacDonald, MB, ChB, PhD as Chief Innovation Officer and Appointment as Chair of Scientific Advisory Board (GlobeNewswire)
Dec-15-23 03:01PM	Insider Sell Alert: Director William White Sells 33,511 Shares of Disc Medicine Inc (IRON) (GuruFocus.com)
Dec-11-23 08:30PM	Disc Presents Positive Updated Results from Phase 2 BEACON Study of Bitopertin and Other Programs at the 65th American Society of Hematology (ASH) Annual Meeting (GlobeNewswire)
12:00PM	Disc Presents Initial Positive Data from Ongoing Phase 1b/2 Trial of DISC-0974 in Patients with Myelofibrosis (MF) and Anemia at the 65th American Society of Hematology (ASH) Annual Meeting (GlobeNewswire)
Dec-08-23 07:06AM	Insider Sell Alert: CFO Joanne Bryce Sells 2,541 Shares of Disc Medicine Inc (IRON) (GuruFocus.com) +5.98%
Nov-14-23 04:44PM	Disc Medicine Announces Grant of US Patent for Methods of Treating Erythropoietic Protoporphyrias with Bitopertin (GlobeNewswire)
Nov-13-23 09:55AM	How Much Upside is Left in Disc Medicine, Inc. (IRON)? Wall Street Analysts Think 38.17% (Zacks)
Nov-09-23 09:34AM	Disc Medicine Inc (IRON) Reports Q3 2023 Financial Results and Business Progress (GuruFocus.com)
08:30AM	Disc Medicine Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
04:30PM	Loading…
Nov-08-23 04:30PM	Disc Medicine to Participate in Upcoming Investor Conferences (GlobeNewswire)
Nov-02-23 09:00AM	Disc Medicine Announces Multiple Presentations Across Portfolio at the 65th American Society of Hematology Annual Meeting and Key Program Updates (GlobeNewswire)
Oct-23-23 09:15AM	Disc Medicine Announces Planned Departure of Chief Financial Officer Joanne Bryce (GlobeNewswire)
Oct-03-23 08:30AM	Disc Medicine Initiates a Phase 1 Study of DISC-3405 (anti-TMPRSS6 mAb) in Healthy Volunteers (GlobeNewswire)
Sep-20-23 04:30PM	Disc Medicine Receives FDA Fast Track Designation for MWTX-003 for the Treatment of Polycythemia Vera (GlobeNewswire)
Aug-30-23 04:15PM	Disc Medicine to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-24-23 11:20AM	Stock Screen Finds These Growth Stocks Outperforming The S&P 500 (Investor's Business Daily)
Aug-11-23 08:50AM	Recent Price Trend in Disc Medicine, Inc. (IRON) is Your Friend, Here's Why (Zacks)
08:00AM	Disc Medicine Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Jul-27-23 09:00AM	Disc Medicine Announces First Patient Enrolled in Phase 1/2 Clinical Trial of Bitopertin in Diamond-Blackfan Anemia (DBA) (GlobeNewswire)
Jul-25-23 09:55AM	Here's Why Disc Medicine, Inc. (IRON) Is a Great 'Buy the Bottom' Stock Now (Zacks)
Jun-22-23 04:15PM	Disc Medicine Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters Option to Purchase Additional Shares (GlobeNewswire)
Jun-20-23 07:33PM	Load Up, Says Raymond James About These 2 Strong Buy Stocks (TipRanks) +7.20%
Jun-13-23 10:39PM	Disc Medicine Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
Jun-12-23 04:00PM	Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire) +6.92%
01:59AM	4 big analyst picks: Adobe a buy on AI hopes, says Wells Fargo (Investing.com)
Jun-09-23 04:13PM	Why Perfectly Rated Disc Medicine, With A 287% Move This Year, Just Put Up Another Big Gain (Investor's Business Daily) +15.76%
07:00AM	Disc Presents Positive Initial Data from Phase 2 BEACON Trial of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) at European Hematology Association (EHA) 2023 Congress (GlobeNewswire)
Jun-01-23 03:10PM	Why Shares of Disc Medicine Opco Climbed This Week (Motley Fool) +7.06%
May-31-23 04:00PM	Disc Medicine to Participate in the Jefferies Healthcare Conference (GlobeNewswire) +12.01%
May-15-23 07:00AM	Disc Medicine Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
May-11-23 10:15AM	Disc Medicine Announces Presentation of Initial Data from Phase 2 BEACON Trial in Patients with Erythropoietic Protoporphyria (EPP) at European Hematology Association (EHA) 2023 Congress (GlobeNewswire)
May-10-23 10:23AM	Is a Surprise Coming for Disc Medicine (IRON) This Earnings Season? (Zacks) +5.24%
May-05-23 08:50AM	Disc Medicine, Inc. (IRON) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
May-04-23 12:00PM	Disc Medicine, Inc. (IRON) Is Up 4.40% in One Week: What You Should Know (Zacks)
Apr-28-23 05:00AM	Zacks.com featured highlights Harrow Health and Disc Medicine Opco (Zacks)
Apr-27-23 08:05AM	2 Stocks in Focus as Analysts Initiate Coverage (Zacks)
Apr-21-23 08:30AM	Disc Medicine to Participate in H.C. Wainwright BioConnect Investor Conference (GlobeNewswire) +11.57%
Apr-19-23 08:50AM	Recent Price Trend in Disc Medicine, Inc. (IRON) is Your Friend, Here's Why (Zacks)
Apr-13-23 11:00AM	Disc Medicine to Host Disease Webinar with KOLs on Erythropoietic Protoporphyria (EPP) (GlobeNewswire)
Mar-31-23 07:00AM	Disc Medicine Reports Full Year 2022 Financial Results and Provides Business Update (GlobeNewswire)
Mar-30-23 07:05AM	Disc Medicine Opco Inc (NASDAQ:IRON) most popular amongst private equity firms who own 48% of the shares, institutions hold 21% (Simply Wall St.)
Mar-21-23 07:00AM	Disc Medicine Announces Collaboration with National Institutes of Health for Phase 2 Clinical Study of Bitopertin in Patients with Diamond-Blackfan Anemia (DBA) (GlobeNewswire)
Feb-16-23 08:00AM	Disc Medicine Initiates a Phase 1b/2 Clinical Study of DISC-0974 in Adults with Non-Dialysis Dependent Chronic Kidney Disease (NDD-CKD) and Anemia (GlobeNewswire)
Feb-14-23 06:30AM	Disc Medicine Announces $62.5 Million Financing led by Bain Capital Life Sciences to Advance Portfolio of Novel Hematology Programs (GlobeNewswire)
Feb-08-23 04:00PM	Disc Medicine to Participate in SVB Securities Global Biopharma Conference (GlobeNewswire)
Jan-20-23 07:00AM	Disc Medicine Announces Exclusive Licensing Agreement with Mabwell Therapeutics for Novel Anti-TMPRSS6 Monoclonal Antibodies to Modulate Iron Homeostasis (GlobeNewswire)

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. The company was founded in October 2017 and is headquartered in Watertown, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Quisel John D	Chief Executive Officer	Jul 08 '24	Option Exercise	1.01	3,000	3,030	72,065	Jul 10 04:15 PM
White William Richard	Director	Jul 01 '24	Option Exercise	9.86	201	1,982	201	Jul 03 04:15 PM
White William Richard	Director	Jul 01 '24	Sale	46.04	201	9,253	0	Jul 03 04:15 PM
Bitterman Kevin	Director	Jun 17 '24	Buy	36.00	222,223	8,000,028	420,549	Jun 20 08:00 PM
Ashiya Mona	Director	Jun 17 '24	Buy	36.00	83,334	3,000,024	941,569	Jun 20 05:27 PM
ORBIMED ADVISORS LLC	Director	Jun 17 '24	Buy	36.00	83,334	3,000,024	941,569	Jun 20 05:19 PM
White William Richard	Director	Jun 03 '24	Option Exercise	3.39	1,957	6,635	1,957	Jun 05 04:05 PM
White William Richard	Director	Jun 03 '24	Sale	36.08	1,957	70,608	0	Jun 05 04:05 PM
White William Richard	Director	May 01 '24	Option Exercise	9.86	201	1,982	201	May 03 04:05 PM
White William Richard	Director	May 01 '24	Sale	28.63	201	5,755	0	May 03 04:05 PM
White William Richard	Director	Apr 11 '24	Option Exercise	4.91	2,560	12,581	2,560	Apr 15 06:27 PM
White William Richard	Director	Apr 11 '24	Sale	31.80	2,560	81,407	0	Apr 15 06:27 PM
Savage William Jacob	Chief Medical Officer	Apr 10 '24	Option Exercise	2.65	21,870	57,956	43,405	Apr 11 05:02 PM
Bitterman Kevin	Director	Mar 05 '24	Sale	73.50	26,157	1,922,540	677,503	Mar 07 04:40 PM
Bitterman Kevin	Director	Jan 23 '24	Sale	67.65	102,500	6,934,125	198,326	Jan 25 04:33 PM
Atlas Venture Fund X, L.P.	10% Owner	Jan 23 '24	Sale	67.65	102,500	6,934,125	198,326	Jan 25 04:31 PM
Atlas Venture Fund X, L.P.	10% Owner	Jan 23 '24	Sale	67.65	47,500	3,213,375	1,402,186	Jan 25 04:31 PM
Atlas Venture Fund X, L.P.	10% Owner	Jan 10 '24	Sale	64.00	30,000	1,920,000	1,449,686	Jan 12 05:12 PM
Bitterman Kevin	Director	Jan 10 '24	Sale	64.00	20,000	1,280,000	786,160	Jan 12 05:12 PM
Atlas Venture Fund X, L.P.	10% Owner	Jan 10 '24	Sale	64.00	20,000	1,280,000	786,160	Jan 12 05:12 PM
Quisel John D	Chief Executive Officer	Dec 29 '23	Option Exercise	1.01	2,700	2,727	2,700	Jan 03 04:05 PM
Bryce Joanne	Chief Financial Officer	Dec 27 '23	Option Exercise	9.86	3,000	29,580	5,500	Dec 29 04:15 PM
Ashiya Mona	Director	Dec 18 '23	Option Exercise	38.00	1,724	65,512	1,724	Dec 20 06:16 PM
ORBIMED ADVISORS LLC	Director	Dec 18 '23	Option Exercise	38.00	1,724	65,512	1,724	Dec 20 06:28 PM
Ashiya Mona	Director	Dec 18 '23	Sale	59.24	1,724	102,130	0	Dec 20 06:16 PM
ORBIMED ADVISORS LLC	Director	Dec 18 '23	Sale	59.24	1,724	102,130	0	Dec 20 06:28 PM
ORBIMED ADVISORS LLC	Director	Dec 14 '23	Sale	56.75	433,200	24,584,100	224,405	Dec 15 06:04 PM
Ashiya Mona	Director	Dec 14 '23	Sale	56.75	433,200	24,584,100	224,405	Dec 15 06:09 PM
Atlas Venture Fund X, L.P.	10% Owner	Dec 14 '23	Sale	58.28	30,825	1,796,437	1,479,686	Dec 14 08:13 PM
Bitterman Kevin	Director	Dec 14 '23	Sale	58.28	20,549	1,197,567	806,160	Dec 14 08:14 PM
Atlas Venture Fund X, L.P.	10% Owner	Dec 14 '23	Sale	58.28	20,549	1,197,567	806,160	Dec 14 08:13 PM
Ashiya Mona	Director	Dec 14 '23	Sale	57.73	200	11,546	727,807	Dec 14 05:40 PM
ORBIMED ADVISORS LLC	Director	Dec 14 '23	Sale	57.73	200	11,546	727,807	Dec 14 05:44 PM
ORBIMED ADVISORS LLC	Director	Dec 13 '23	Sale	58.56	106,700	6,248,352	281,505	Dec 14 05:44 PM
Ashiya Mona	Director	Dec 13 '23	Sale	58.56	106,700	6,248,352	281,505	Dec 14 05:40 PM
Atlas Venture Fund X, L.P.	10% Owner	Dec 13 '23	Sale	60.00	5,323	319,357	1,510,511	Dec 14 08:13 PM
Atlas Venture Fund X, L.P.	10% Owner	Dec 13 '23	Sale	60.00	3,548	212,865	826,709	Dec 14 08:13 PM
Bitterman Kevin	Director	Dec 13 '23	Sale	60.00	3,548	212,865	826,709	Dec 14 08:14 PM
White William Richard	Director	Dec 12 '23	Option Exercise	6.08	33,511	203,883	33,511	Dec 14 04:15 PM
Bryce Joanne	Chief Financial Officer	Dec 12 '23	Option Exercise	2.65	2,500	6,625	5,000	Dec 14 04:15 PM
Atlas Venture Fund X, L.P.	10% Owner	Dec 12 '23	Sale	62.80	77,951	4,895,032	1,515,834	Dec 14 08:13 PM
Bitterman Kevin	Director	Dec 12 '23	Sale	62.80	51,967	3,263,328	830,257	Dec 14 08:14 PM
Atlas Venture Fund X, L.P.	10% Owner	Dec 12 '23	Sale	62.80	51,967	3,263,328	830,257	Dec 14 08:13 PM
White William Richard	Director	Dec 12 '23	Sale	63.21	33,511	2,118,239	0	Dec 14 04:15 PM
Ashiya Mona	Director	Dec 12 '23	Sale	60.16	27,300	1,642,368	295,605	Dec 14 05:40 PM
ORBIMED ADVISORS LLC	Director	Dec 12 '23	Sale	60.16	27,300	1,642,368	295,605	Dec 14 05:44 PM
Bryce Joanne	Chief Financial Officer	Dec 12 '23	Sale	65.22	2,500	163,062	2,500	Dec 14 04:15 PM
Bryce Joanne	Chief Financial Officer	Dec 05 '23	Option Exercise	1.01	1,281	1,294	5,041	Dec 07 04:15 PM
Bryce Joanne	Chief Financial Officer	Dec 05 '23	Sale	56.00	2,541	142,299	2,500	Dec 07 04:15 PM
Khara Rahul	General Counsel	Nov 22 '23	Option Exercise	14.69	10,000	146,900	10,000	Nov 27 04:15 PM
Khara Rahul	General Counsel	Nov 22 '23	Sale	51.73	10,000	517,333	0	Nov 27 04:15 PM
Khara Rahul	General Counsel	Nov 14 '23	Option Exercise	14.69	4,900	71,981	4,900	Nov 15 05:00 PM
Khara Rahul	General Counsel	Nov 14 '23	Sale	50.61	4,900	248,012	0	Nov 15 05:00 PM
Khara Rahul	General Counsel	Nov 03 '23	Option Exercise	14.69	100	1,469	100	Nov 07 06:22 PM
Khara Rahul	General Counsel	Nov 03 '23	Sale	50.00	100	5,000	0	Nov 07 06:22 PM
Atlas Venture Fund X, L.P.	10% Owner	Sep 16 '23	Sale	53.22	2,115	112,560	1,593,785	Sep 18 04:59 PM
Atlas Venture Fund X, L.P.	10% Owner	Sep 15 '23	Sale	53.16	260,894	13,869,125	1,595,900	Sep 18 04:59 PM
Atlas Venture Fund X, L.P.	10% Owner	Sep 14 '23	Sale	53.05	94,440	5,010,042	1,856,794	Sep 18 04:59 PM
Bryce Joanne	Chief Financial Officer	Sep 11 '23	Option Exercise	9.86	2,500	24,650	3,760	Sep 13 04:15 PM
Bryce Joanne	Chief Financial Officer	Sep 01 '23	Option Exercise	2.65	1,000	2,650	2,260	Sep 05 04:16 PM
Bryce Joanne	Chief Financial Officer	Sep 01 '23	Sale	52.99	1,000	52,990	1,260	Sep 05 04:16 PM
Savage William Jacob	Chief Medical Officer	Aug 21 '23	Option Exercise	2.65	3,000	7,950	3,000	Aug 22 04:06 PM
Atlas Venture Fund X, L.P.	10% Owner	Aug 15 '23	Sale	52.40	111,069	5,820,016	1,951,234	Aug 16 06:55 PM
Bitterman Kevin	Director	Aug 15 '23	Sale	52.40	72,931	3,821,584	882,224	Aug 17 04:13 PM
Atlas Venture Fund X, L.P.	10% Owner	Aug 15 '23	Sale	52.40	72,931	3,821,584	882,224	Aug 16 06:55 PM
Savage William Jacob	Chief Medical Officer	Aug 15 '23	Sale	52.95	7,672	406,235	0	Aug 16 04:15 PM
Atlas Venture Fund X, L.P.	10% Owner	Aug 14 '23	Sale	52.59	175,000	9,203,600	2,062,303	Aug 16 06:55 PM
Savage William Jacob	Chief Medical Officer	Aug 09 '23	Sale	49.83	8,269	412,064	7,672	Aug 11 04:15 PM
Bryce Joanne	Chief Financial Officer	Aug 01 '23	Option Exercise	1.01	4,521	4,566	5,781	Aug 03 04:18 PM
Bryce Joanne	Chief Financial Officer	Aug 01 '23	Sale	49.91	4,521	225,633	1,260	Aug 03 04:18 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IRON

Disc Medicine Inc

Upgrade your FINVIZ experience